Treating anaemia: damned if you do, damned if you don’t

Mary Rice

Many cancer patients suffer unnecessary levels of fatigue due to a failure to treat their anaemia. But just as the cost of erythropoiesis-stimulating proteins looks set to fall, surprise research results are prompting questions over whether these drugs might actually be stimulating tumour growth.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1